RBMX
Basic information
Region (hg38): X:136848004-136880764
Links
Phenotypes
GenCC
Source:
- syndromic X-linked intellectual disability Shashi type (Moderate), mode of inheritance: XL
- syndromic X-linked intellectual disability Shashi type (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, X-linked, syndromic 11 (Shashi type); Intellectual developmental disorder, X-linked syndromic, Gustavson type | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic | 10677307; 25256757; 37277488 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBMX gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 10 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 4 | |||||
Total | 0 | 1 | 16 | 3 | 2 |
Variants in RBMX
This is a list of pathogenic ClinVar variants found in the RBMX region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-136872324-CATA-C | RBMX-related disorder | Benign (Dec 06, 2019) | ||
X-136872325-A-AT | Severe X-linked intellectual disability, Gustavson type | Uncertain significance (Mar 29, 2024) | ||
X-136874213-G-A | Inborn genetic diseases | Uncertain significance (Sep 17, 2021) | ||
X-136874250-C-A | Likely benign (Apr 01, 2024) | |||
X-136874258-CCATAGAAGGGGGAAGCCCTCTTT-C | Syndromic X-linked intellectual disability Shashi type | Pathogenic (Mar 13, 2024) | ||
X-136874266-G-C | Uncertain significance (Jun 01, 2023) | |||
X-136874287-C-T | Syndromic X-linked intellectual disability Shashi type | Uncertain significance (Jan 04, 2022) | ||
X-136874321-C-A | Syndromic X-linked intellectual disability Shashi type | Uncertain significance (Jul 15, 2020) | ||
X-136874381-AATC-A | RBMX-related disorder | Uncertain significance (Feb 14, 2024) | ||
X-136874427-T-C | not specified | Likely benign (Mar 28, 2016) | ||
X-136874429-T-C | Inborn genetic diseases | Uncertain significance (Mar 30, 2024) | ||
X-136874453-C-CATAACTCTCATA | CIC-rearranged sarcoma | not provided (-) | ||
X-136875144-A-C | Inborn genetic diseases | Uncertain significance (Jun 10, 2024) | ||
X-136875254-T-G | not specified | Likely benign (Aug 15, 2017) | ||
X-136875323-T-C | Inborn genetic diseases | Conflicting classifications of pathogenicity (Nov 14, 2024) | ||
X-136875466-A-G | Uncertain significance (Mar 01, 2022) | |||
X-136875536-T-C | Syndromic X-linked intellectual disability Shashi type | Uncertain significance (Feb 18, 2020) | ||
X-136876506-T-C | not specified | Uncertain significance (Feb 08, 2024) | ||
X-136876557-TAGG-T | Severe X-linked intellectual disability, Gustavson type | Pathogenic (Mar 13, 2024) | ||
X-136876650-C-A | Inborn genetic diseases | Uncertain significance (May 04, 2023) | ||
X-136876663-A-G | Syndromic X-linked intellectual disability Shashi type | Uncertain significance (May 03, 2020) | ||
X-136876672-A-G | not specified | Uncertain significance (Jul 06, 2023) | ||
X-136877915-C-A | Severe X-linked intellectual disability, Gustavson type | Likely pathogenic (Mar 25, 2024) | ||
X-136877996-T-C | Inborn genetic diseases | Uncertain significance (Sep 08, 2024) | ||
X-136878001-C-T | Inborn genetic diseases | Uncertain significance (Feb 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBMX | protein_coding | protein_coding | ENST00000320676 | 8 | 32761 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.829 | 0.171 | 124927 | 0 | 3 | 124930 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.90 | 62 | 168 | 0.369 | 0.0000139 | 2424 |
Missense in Polyphen | 18 | 43.401 | 0.41474 | 733 | ||
Synonymous | -0.498 | 54 | 49.5 | 1.09 | 0.00000353 | 809 |
Loss of Function | 3.05 | 2 | 14.6 | 0.137 | 0.00000127 | 258 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000367 | 0.0000367 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000263 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein that plays several role in the regulation of pre- and post-transcriptional processes. Implicated in tissue-specific regulation of gene transcription and alternative splicing of several pre-mRNAs. Binds to and stimulates transcription from the tumor suppressor TXNIP gene promoter; may thus be involved in tumor suppression. When associated with SAFB, binds to and stimulates transcription from the SREBF1 promoter. Associates with nascent mRNAs transcribed by RNA polymerase II. Component of the supraspliceosome complex that regulates pre-mRNA alternative splice site selection. Can either activate or suppress exon inclusion; acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN2. Represses the splicing of MAPT/Tau exon 10. Binds preferentially to single- stranded 5'-CC[A/C]-rich RNA sequence motifs localized in a single-stranded conformation; probably binds RNA as a homodimer. Binds non-specifically to pre-mRNAs. Plays also a role in the cytoplasmic TNFR1 trafficking pathways; promotes both the IL-1- beta-mediated inducible proteolytic cleavage of TNFR1 ectodomains and the release of TNFR1 exosome-like vesicles to the extracellular compartment. {ECO:0000269|PubMed:12165565, ECO:0000269|PubMed:12761049, ECO:0000269|PubMed:16707624, ECO:0000269|PubMed:18445477, ECO:0000269|PubMed:18541147, ECO:0000269|PubMed:19282290, ECO:0000269|PubMed:21327109}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Spliceosome - Homo sapiens (human);mRNA Processing;Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Intolerance Scores
- loftool
- 0.132
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.11
Haploinsufficiency Scores
- pHI
- 0.261
- hipred
- Y
- hipred_score
- 0.698
- ghis
- 0.540
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.970
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbmx
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; immune system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;osteoblast differentiation;transcription by RNA polymerase II;mRNA splice site selection;membrane protein ectodomain proteolysis;RNA metabolic process;positive regulation of transcription by RNA polymerase II;negative regulation of mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome;protein complex oligomerization;protein homooligomerization;cellular response to interleukin-1
- Cellular component
- extracellular space;nucleus;nucleoplasm;spliceosomal complex;nuclear euchromatin;membrane;supraspliceosomal complex;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;chromatin binding;RNA binding;single-stranded RNA binding;mRNA binding;protein binding;protein domain specific binding;identical protein binding